Qiang Liu
교수
Tianjin Medical University General Hospital
China
E-Mail: qliu@tmu.edu.cn
약력
2023 ~ Clinical Director of Epilepsy Division
VP of Tianjin Medical University General Hospital
VP of Tianjin Institute of Immunology, Tianjin, China
2018 ~ Physician and Professor of Neurology
Director of Neurodegenerative Diseases Research Lab, VP of Tianjin
Neurological Institute, Tianjin Medical University General Hospital, Tianjin,
China
2017 ~ 2020 Arizona State University, Tempe, Arizona, USA
Adjunct Professor of Neuroscience Associate
2017 ~ 2019 University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA
Adjunct Professor of Neurology
2016 ~ 2018 Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA Tenure-Track Assistant Professor
강의 제목
Bone Marrow Hematopoiesis in CNS Inflammation
강의 내용
B cells drive the immunopathology of autoimmune diseases. Bone marrow hematopoietic stem and progenitor cells (HSPCs) sense immune activation and instruct systemic immunity. However, the alterations in HSPCs in B cell-mediated autoimmune diseases and their impact on disease progression remain unknown. Neuromyelitis optica spectrum disorder (NMOSD) is a B cell-mediated autoimmune neurological disease that involves anti–aquaporin-4 autoantibodies (AQP4-IgG). Herein, we show aberrant bone marrow granulopoiesis in patients with NMOSD, accompanied by the expansion of B cell clones. This aberrant granulopoiesis was mediated by the hyperactivity of the JAK-STAT pathway, leading to a dramatic increase of ISG15+ neutrophils that produced BAFF to drive the maturation of antibody-secreting cells and AQP4-IgG production. This effect was also observed in patients with NMOSD receiving B cell depletion therapy who experienced relapse. In patients with NMOSD, belimumab, a monoclonal antibody against BAFF, reduced the rate of disease relapse, the number of antibody-secreting cells and the AQP4-IgG titer. Thus, targeting the bone marrow niche may present a new strategy for the treatment of NMOSD and perhaps other B cell- mediated autoimmune diseases.
관련 논문
Liu M, Wang D, Qi C, Zou M, Song J, Li L, Xie H, Ren H, Hao H, Yang G, Li Z, Zhang Q*, Zhou J*, Ai D*, Liu Q*. Brain ischemia sustains systemic endothelial Notch1 activity to accelerate atherosclerosis. Immunity. 2024 In press. *Co-corresponding authors.
Cui Z, Xu H, Wu F, Chen J, Zhu L, Shen Z, Yi X, Yang J, Jia C, Zhang L, Zhou P, Li MJ, Zhu L, Duan S, Yao Z, Yu Y*, Liu Q*, Zhou J*. Maternal circadian rhythm disruption affects neonatal inflammation via metabolic reprograming of myeloid cells. Nat Metab. 2024;6:899. *Co-corresponding authors. PMID: 38561509
Zhang W, Sun HS, Wang X, Dumont AS, Liu Q. Cellular senescence, DNA damage, and neuroinflammation in the aging brain. Trends Neurosci. 2024:S0166-2236(24)00061. PMID: 38729785
Cao Y, Li Y, Wang X, Liu S, Zhang Y, Liu G, Ye S, Zheng Y, Zhao J, Zhu X, Chen Y, Xu H, Feng D, Chen D, Chen L, Liu W, Zhou W, Zhang Z, Zhou P, Deng K, Ye L, Yu Y, Yao Z, Liu Q, Xu H, Zhou J. Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity. Immunity. 2023:S1074-7613(22)00675-6. PMID: 36693372
Shi K, Li H, Chang T, He W, Kong Y, Qi C, Li R, Huang H, Zhu Z, Zheng P, Ruan Z, Zhou J, Shi FD, Liu Q. Bone marrow hematopoiesis drives multiple sclerosis progression. Cell. 2022;185:2234-2247. PMID: 35709748